Page results
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
This page explains what sperm banking is, how it works and how it can benefit you.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2023/0481 - Closure of maternity unit to new admissions 2018/23
-
FOI201776 Serious incidents and deaths of patients with a learning disability
-
FOI201779 Arthritis treatments for patients
-
FOI201780 Training on the Prevent Strategy
-
FOI201782 Maternity services
-
FOI201784 Premature births
-
FOI201785 Opthalmology treatments
-
FOI201786 EU national staff leaving posts
-
FOI/2023/0471 - Treatment of HIV & PrEP
-
FOI/2023/0474 - Number of live births, still births and neonatal deaths